Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-20 22:13:31 UTC |
---|
Update Date | 2023-02-21 17:15:49 UTC |
---|
HMDB ID | HMDB0001842 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Guanidine |
---|
Description | Guanidine, also known as Gu or H2N-C(=nh)-NH2, belongs to the class of organic compounds known as guanidines. Guanidines are compounds containing a guanidine moiety, with the general structure (R1R2N)(R3R4N)C=N-R5. Guanidine is a drug which is used for the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of eaton-lambert. it is not indicated for treating myasthenia gravis. Guanidine is a very strong basic compound (based on its pKa). In humans, guanidine is involved in the metabolic disorder called the adenosine deaminase deficiency pathway. Outside of the human body, Guanidine has been detected, but not quantified in, several different foods, such as apples, corns, loquats, rices, and soy beans. This could make guanidine a potential biomarker for the consumption of these foods. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Guanidine is a potentially toxic compound. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Severe guanidine intoxication is characterized by nervous hyperirritability, fibrillary tremors and convulsive contractions of muscle, salivation, vomiting, diarrhea, hypoglycemia, and circulatory disturbances. Guanidine apparently acts by enhancing the release of acetylcholine following a nerve impulse. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869). Kidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored. |
---|
Structure | InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4) |
---|
Synonyms | Value | Source |
---|
Aminomethanamidine | ChEBI | Gu | ChEBI | Guanidin | ChEBI | H2N-C(=nh)-NH2 | ChEBI | Iminourea | ChEBI | Carbamidine | Kegg | (4-Aminobutyl) guanidine | HMDB | Aminoformamidine | HMDB | Carbamamidine | HMDB | Imidourea | HMDB | Guanidine hydrochloride | HMDB | Guanidine monohydrate | HMDB | Guanidine monohydrochloride | HMDB | Guanidine sulfate | HMDB | Guanidium chloride | HMDB | Chloride, guanidinium | HMDB | Guanidine monohydroiodine | HMDB | Guanidine sulfate (1:1) | HMDB | Guanidine sulfate (2:1) | HMDB | Guanidine sulfite (1:1) | HMDB | Guanidinium | HMDB | Hydrochloride, guanidine | HMDB | Monohydrobromide, guanidine | HMDB | Monohydrochloride, guanidine | HMDB | Phosphate, guanidine | HMDB | Guanidine monohydrobromide | HMDB | Guanidine phosphate | HMDB | Monohydroiodine, guanidine | HMDB | Nitrate, guanidine | HMDB | Chloride, guanidium | HMDB | Guanidine nitrate | HMDB | Guanidinium chloride | HMDB | Monohydrate, guanidine | HMDB | Sulfate, guanidine | HMDB |
|
---|
Chemical Formula | CH5N3 |
---|
Average Molecular Weight | 59.0705 |
---|
Monoisotopic Molecular Weight | 59.048347175 |
---|
IUPAC Name | guanidine |
---|
Traditional Name | guanidine |
---|
CAS Registry Number | 50-01-1 |
---|
SMILES | NC(N)=N |
---|
InChI Identifier | InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4) |
---|
InChI Key | ZRALSGWEFCBTJO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as guanidines. Guanidines are compounds containing a guanidine moiety, with the general structure (R1R2N)(R3R4N)C=N-R5. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Guanidines |
---|
Direct Parent | Guanidines |
---|
Alternative Parents | |
---|
Substituents | - Guanidine
- Carboximidamide
- Organopnictogen compound
- Hydrocarbon derivative
- Imine
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 182.3 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 829 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 116.716 | 30932474 | DeepCCS | [M-H]- | 114.839 | 30932474 | DeepCCS | [M-2H]- | 150.089 | 30932474 | DeepCCS | [M+Na]+ | 124.072 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Guanidine,1TMS,isomer #1 | C[Si](C)(C)NC(=N)N | 1308.3 | Semi standard non polar | 33892256 | Guanidine,1TMS,isomer #1 | C[Si](C)(C)NC(=N)N | 1045.8 | Standard non polar | 33892256 | Guanidine,1TMS,isomer #1 | C[Si](C)(C)NC(=N)N | 2047.5 | Standard polar | 33892256 | Guanidine,1TMS,isomer #2 | C[Si](C)(C)N=C(N)N | 1225.5 | Semi standard non polar | 33892256 | Guanidine,1TMS,isomer #2 | C[Si](C)(C)N=C(N)N | 1054.4 | Standard non polar | 33892256 | Guanidine,1TMS,isomer #2 | C[Si](C)(C)N=C(N)N | 1938.4 | Standard polar | 33892256 | Guanidine,2TMS,isomer #1 | C[Si](C)(C)NC(=N)N[Si](C)(C)C | 1434.3 | Semi standard non polar | 33892256 | Guanidine,2TMS,isomer #1 | C[Si](C)(C)NC(=N)N[Si](C)(C)C | 1169.0 | Standard non polar | 33892256 | Guanidine,2TMS,isomer #1 | C[Si](C)(C)NC(=N)N[Si](C)(C)C | 2074.6 | Standard polar | 33892256 | Guanidine,2TMS,isomer #2 | C[Si](C)(C)N(C(=N)N)[Si](C)(C)C | 1420.0 | Semi standard non polar | 33892256 | Guanidine,2TMS,isomer #2 | C[Si](C)(C)N(C(=N)N)[Si](C)(C)C | 1183.5 | Standard non polar | 33892256 | Guanidine,2TMS,isomer #2 | C[Si](C)(C)N(C(=N)N)[Si](C)(C)C | 1993.1 | Standard polar | 33892256 | Guanidine,2TMS,isomer #3 | C[Si](C)(C)N=C(N)N[Si](C)(C)C | 1393.7 | Semi standard non polar | 33892256 | Guanidine,2TMS,isomer #3 | C[Si](C)(C)N=C(N)N[Si](C)(C)C | 1164.3 | Standard non polar | 33892256 | Guanidine,2TMS,isomer #3 | C[Si](C)(C)N=C(N)N[Si](C)(C)C | 1911.6 | Standard polar | 33892256 | Guanidine,3TMS,isomer #1 | C[Si](C)(C)NC(=N)N([Si](C)(C)C)[Si](C)(C)C | 1463.8 | Semi standard non polar | 33892256 | Guanidine,3TMS,isomer #1 | C[Si](C)(C)NC(=N)N([Si](C)(C)C)[Si](C)(C)C | 1286.4 | Standard non polar | 33892256 | Guanidine,3TMS,isomer #1 | C[Si](C)(C)NC(=N)N([Si](C)(C)C)[Si](C)(C)C | 1830.3 | Standard polar | 33892256 | Guanidine,3TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N[Si](C)(C)C | 1428.0 | Semi standard non polar | 33892256 | Guanidine,3TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N[Si](C)(C)C | 1216.4 | Standard non polar | 33892256 | Guanidine,3TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N[Si](C)(C)C | 1931.6 | Standard polar | 33892256 | Guanidine,3TMS,isomer #3 | C[Si](C)(C)N=C(N)N([Si](C)(C)C)[Si](C)(C)C | 1450.4 | Semi standard non polar | 33892256 | Guanidine,3TMS,isomer #3 | C[Si](C)(C)N=C(N)N([Si](C)(C)C)[Si](C)(C)C | 1303.4 | Standard non polar | 33892256 | Guanidine,3TMS,isomer #3 | C[Si](C)(C)N=C(N)N([Si](C)(C)C)[Si](C)(C)C | 1918.9 | Standard polar | 33892256 | Guanidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=N)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1496.5 | Semi standard non polar | 33892256 | Guanidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=N)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1465.6 | Standard non polar | 33892256 | Guanidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=N)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1732.2 | Standard polar | 33892256 | Guanidine,4TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1428.4 | Semi standard non polar | 33892256 | Guanidine,4TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1324.8 | Standard non polar | 33892256 | Guanidine,4TMS,isomer #2 | C[Si](C)(C)N=C(N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1691.0 | Standard polar | 33892256 | Guanidine,5TMS,isomer #1 | C[Si](C)(C)N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1568.2 | Semi standard non polar | 33892256 | Guanidine,5TMS,isomer #1 | C[Si](C)(C)N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1516.7 | Standard non polar | 33892256 | Guanidine,5TMS,isomer #1 | C[Si](C)(C)N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1465.1 | Standard polar | 33892256 | Guanidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N | 1477.1 | Semi standard non polar | 33892256 | Guanidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N | 1166.9 | Standard non polar | 33892256 | Guanidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N | 2290.4 | Standard polar | 33892256 | Guanidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N)N | 1387.3 | Semi standard non polar | 33892256 | Guanidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N)N | 1237.1 | Standard non polar | 33892256 | Guanidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N)N | 2167.3 | Standard polar | 33892256 | Guanidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N[Si](C)(C)C(C)(C)C | 1883.9 | Semi standard non polar | 33892256 | Guanidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N[Si](C)(C)C(C)(C)C | 1509.4 | Standard non polar | 33892256 | Guanidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N[Si](C)(C)C(C)(C)C | 2073.6 | Standard polar | 33892256 | Guanidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=N)N)[Si](C)(C)C(C)(C)C | 1760.7 | Semi standard non polar | 33892256 | Guanidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=N)N)[Si](C)(C)C(C)(C)C | 1553.1 | Standard non polar | 33892256 | Guanidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=N)N)[Si](C)(C)C(C)(C)C | 2107.0 | Standard polar | 33892256 | Guanidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N[Si](C)(C)C(C)(C)C | 1765.9 | Semi standard non polar | 33892256 | Guanidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N[Si](C)(C)C(C)(C)C | 1449.5 | Standard non polar | 33892256 | Guanidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N[Si](C)(C)C(C)(C)C | 2109.4 | Standard polar | 33892256 | Guanidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2041.3 | Semi standard non polar | 33892256 | Guanidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1912.8 | Standard non polar | 33892256 | Guanidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2061.7 | Standard polar | 33892256 | Guanidine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2035.5 | Semi standard non polar | 33892256 | Guanidine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 1742.0 | Standard non polar | 33892256 | Guanidine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2063.8 | Standard polar | 33892256 | Guanidine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1961.5 | Semi standard non polar | 33892256 | Guanidine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1876.5 | Standard non polar | 33892256 | Guanidine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N=C(N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2208.7 | Standard polar | 33892256 | Guanidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2265.7 | Semi standard non polar | 33892256 | Guanidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2271.0 | Standard non polar | 33892256 | Guanidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2087.3 | Standard polar | 33892256 | Guanidine,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2208.9 | Semi standard non polar | 33892256 | Guanidine,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2087.9 | Standard non polar | 33892256 | Guanidine,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N=C(N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2043.4 | Standard polar | 33892256 | Guanidine,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2484.6 | Semi standard non polar | 33892256 | Guanidine,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2431.0 | Standard non polar | 33892256 | Guanidine,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1995.1 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Guanidine GC-MS (3 TMS) | splash10-00dj-0920000000-b2c19a9125b059b573fd | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Guanidine GC-MS (Non-derivatized) | splash10-00dj-0920000000-b2c19a9125b059b573fd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Guanidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9000000000-6e00e9be1957670e422b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Guanidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanidine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-03di-9000000000-4df2949d18a754b6aa19 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanidine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0006-9000000000-18b92fabd8878a75412f | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanidine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9000000000-6675e99565dbe0735311 | 2012-07-24 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 10V, Positive-QTOF | splash10-03di-9000000000-0bf566c21de369198214 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 20V, Positive-QTOF | splash10-03di-9000000000-b4670d41c5cfae856086 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 40V, Positive-QTOF | splash10-03dl-9000000000-9431377731da436c5aa7 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 10V, Negative-QTOF | splash10-0a4i-9000000000-2280b2044ac4a1f8b7fb | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 20V, Negative-QTOF | splash10-0a4i-9000000000-8278836749ed05b02fb3 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 40V, Negative-QTOF | splash10-0006-9000000000-154d1302bda42480ad7b | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 10V, Positive-QTOF | splash10-0006-9000000000-ab782a456c989f06bfc8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 20V, Positive-QTOF | splash10-0006-9000000000-36e3aa30c6cc4afb2049 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 40V, Positive-QTOF | splash10-0006-9000000000-36e3aa30c6cc4afb2049 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 10V, Negative-QTOF | splash10-0006-9000000000-1c8520c5f7efb1187e43 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 20V, Negative-QTOF | splash10-0006-9000000000-1c8520c5f7efb1187e43 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanidine 40V, Negative-QTOF | splash10-0006-9000000000-1c8520c5f7efb1187e43 | 2021-09-23 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | - Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Brain
- Cartilage
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Pancreas
- Placenta
- Platelet
- Skeletal Muscle
- Spleen
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.13 (0.06-0.2) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.24 +/- 0.08 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | <0.20 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | <0.200 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.5 (0.20-0.78) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0 - 0.1 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.42 +/- 0.24 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | Urine | Detected and Quantified | 11.85-22.02 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 3.1 +/- 1.1 uM | Adult (>18 years old) | Both | Chronic renal failure | | details | Blood | Detected and Quantified | 0.4 (0.06-0.35) uM | Adult (>18 years old) | Both | Cirrhosis | | details | Blood | Detected and Quantified | 1.63 +/- 0.17 uM | Adult (>18 years old) | Both | uremia | | details | Blood | Detected and Quantified | 2.931 +/- 1.420 uM | Adult (>18 years old) | Both | Uremia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Cirrhosis |
---|
- Marescau B, De Deyn PP, Holvoet J, Possemiers I, Nagels G, Saxena V, Mahler C: Guanidino compounds in serum and urine of cirrhotic patients. Metabolism. 1995 May;44(5):584-8. [PubMed:7752905 ]
| Chronic renal failure |
---|
- Kikuchi T, Orita Y, Ando A, Mikami H, Fujii M, Okada A, Abe H: Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. Clin Chem. 1981 Nov;27(11):1899-902. [PubMed:7296840 ]
| Uremia |
---|
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
|
|
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00536 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB005416 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 3400 |
---|
KEGG Compound ID | C17349 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Guanidine |
---|
METLIN ID | 6342 |
---|
PubChem Compound | 3520 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 42820 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | M02035 |
---|
MarkerDB ID | MDB00013442 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM: Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest. 1993 Jun;91(6):2488-96. [PubMed:8514861 ]
- Lorenzo P, Bayliss MT, Heinegard D: A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem. 1998 Sep 4;273(36):23463-8. [PubMed:9722583 ]
- Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E: Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol. 1999 Jul;56(1):1-10. [PubMed:10385678 ]
- Mizutani N, Hayakawa C, Ohya Y, Watanabe K, Watanabe Y, Mori A: Guanidino compounds in hyperargininemia. Tohoku J Exp Med. 1987 Nov;153(3):197-205. [PubMed:3433275 ]
- Atlas D: Molecular and physiological properties of clonidine-displacing substance. Ann N Y Acad Sci. 1995 Jul 12;763:314-24. [PubMed:7677341 ]
- De Deyn PP, Marescau B, D'Hooge R, Possemiers I, Nagler J, Mahler C: Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int. 1995 Sep;27(3):227-37. [PubMed:8520461 ]
- Bullough A, Karadia S, Watters M: Phaeochromocytoma: an unusual cause of hypertension in pregnancy. Anaesthesia. 2001 Jan;56(1):43-6. [PubMed:11167434 ]
- Mannik M, Person RE: Deep penetration of antibodies into the articular cartilage of patients with rheumatoid arthritis. Rheumatol Int. 1994;14(3):95-102. [PubMed:7839077 ]
- Eropkin MIu, Smirnova TD, Eropkina EM, Mamaeva EG: [The study of the Ca2+ role in cytotoxic response of human cells in culture to the action of xenobiotics]. Tsitologiia. 2000;42(2):154-9. [PubMed:10752119 ]
- Rufanova VA, Sorokin A: CrkII associates with BCAR3 in response to endothelin-1 in human glomerular mesangial cells. Exp Biol Med (Maywood). 2006 Jun;231(6):752-6. [PubMed:16740993 ]
- Bjornsson S: Size-dependent separation of proteoglycans by electrophoresis in gels of pure agarose. Anal Biochem. 1993 May 1;210(2):292-8. [PubMed:8512064 ]
- Sakamoto N, Toge T, Nishiyama M: Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation. Hiroshima J Med Sci. 1997 Jun;46(2):67-73. [PubMed:9232934 ]
- Dabaghian RH, Barnard G, McConnell I, Clewley JP: An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry. J Virol Methods. 2006 Mar;132(1-2):85-91. Epub 2005 Oct 10. [PubMed:16219367 ]
- Gothert M, Bruss M, Bonisch H, Molderings GJ: Presynaptic imidazoline receptors. New developments in characterization and classification. Ann N Y Acad Sci. 1999 Jun 21;881:171-84. [PubMed:10415912 ]
- Okumi M, Ueda T, Ichimaru N, Fujimoto N, Itoh K: [A case of composite pheochromocytoma-ganglioneuroblastoma in the adrenal gland with primary hyperparathyroidism]. Hinyokika Kiyo. 2003 May;49(5):269-72. [PubMed:12822455 ]
- Rubello D, Bui C, Casara D, Gross MD, Fig LM, Shapiro B: Functional scintigraphy of the adrenal gland. Eur J Endocrinol. 2002 Jul;147(1):13-28. [PubMed:12088915 ]
- Wang JG, Lemon SM: Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J Virol. 1993 Jan;67(1):446-54. [PubMed:7677957 ]
- Maruta K, Sonoda Y, Saigo R, Yoshioka T, Fukunaga H: [A patient with von Recklinghausen's disease associated with polymyositis, asymptomatic pheochromocytoma, and primary hepatic leiomyosarcoma]. Nihon Ronen Igakkai Zasshi. 2004 May;41(3):339-43. [PubMed:15237755 ]
- Noyori K, Koshino T, Takagi T, Okamoto R, Jasin HE: Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage. J Rheumatol. 1994 Feb;21(2):293-6. [PubMed:8182639 ]
- Tapiero H, Mathe G, Couvreur P, Tew KD: I. Arginine. Biomed Pharmacother. 2002 Nov;56(9):439-45. [PubMed:12481980 ]
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
|
---|